SHORT MINI FUTURE - BAYER | Market Closed - Swiss Exchange 16:20:00 03/06/2024 BST | ||
| 1.76 CHF | -2.22% |
|
| Current month | -2.22% | ||
| 1 month | -2.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
Latest news about BAYER AG
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.76 | -2.22% |
| 31/05/24 | 1.8 | -1.10% |
| 30/05/24 | 1.82 | -5.21% |
| 29/05/24 | 1.92 | +3.23% |
| 28/05/24 | 1.86 | +2.20% |
Delayed Quote Swiss Exchange
Last update June 03, 2024 at 04:20 pm
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | 
Vontobel
|
| MBAB2V | |
| ISIN | CH1290676142 |
| Date issued | 19/10/2023 |
| Strike | 46.33 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.4 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 2 CHF |
|---|---|
| Lowest since issue | 0.42 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.57% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.24
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.73%
- Stock Market
- Certificates
- MBAB2V Certificat
